Pacific Edge has the ‘edge’ at NZBIO Awards
Tuesday 13th May 2014
We are delighted to announce that Pacific Edge has won the Biotech Company of the Year award at the NZBIO Annual Excellence Awards Dinner on 29 April 2014. Pacific Edge is a cancer diagnostics company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer.
Established in 2001, Pacific Edge identifies unique gene and protein signatures for the development of better cancer management tools by combining state of the art molecular biology, gene expression analysis and signature development, validation with world-class tissue banks and clinical data and proprietary analytical software.
They provide a centralised diagnostic service through their own facilities in New Zealand and the United States or as a turnkey solution, licensed to selected partners. Pacific Edge has plans to further engage with leading medical and urological opinion leaders who will be vital to success in new markets.
The awards ceremony was held at The Langham Hotel in Auckland and celebrates the past year’s biotechnology successes.
“We are fortunate to have had the opportunity to assist Pacific Edge and this award is well deserved recognition for its innovation and successful business model.” says Jared Scarlett, Senior Associate, Baldwins.
Congratulations to the team at Pacific Edge.
For more information on Pacific Edge, visit their website -www.pacificedgedx.com